TY - JOUR
T1 - Dynamic interactions of ceftriaxone and environmental variables suppress amphetamine seeking
AU - Garcia, Erik J.
AU - Arndt, David L.
AU - Cain, Mary E.
N1 - Funding Information:
This work was supported by The National Institute on Drug Abuse , grant DA035435 . DLA was supported by grant DA035435. EJG was supported by grant DA035435-S1. The authors do not have any conflicts of interests that would confound the interpretation of the research or data presented. The biochemical results were collected at the Molecular Biology Core supported by the College of Veterinary Medicine at Kansas State University.
Publisher Copyright:
© 2019
PY - 2019/6/1
Y1 - 2019/6/1
N2 - Extrasynaptic glutamate within the nucleus accumbens (NAc) is a driver of relapse. Cocaine, ethanol, and methamphetamine reduce the expression of cystine-glutamate antiporter (xCT) and primary glial glutamate transporter 1 (GLT1) leading to increased extrasynaptic glutamate. Ceftriaxone (CTX) restores xCT and GLT1 expression and effectively suppresses cocaine and ethanol reinstatement, however, the effects of CTX on amphetamine (AMP) reinstatement are not determined. Rodents were reared in an enriched condition (EC), isolated (IC), or standard condition (SC) and trained in AMP self-administration (0.1 mg/kg/infusion). EC, IC, and SC rats received injections of SAL or CTX (200 mg/kg) after daily extinction sessions. Then rats were tested in cue- and AMP-induced reinstatement tests. We hypothesized that EC rearing would reduce reinstatement by altering GLT1 or xCT expression in the NAc and medial prefrontal cortex (mPFC). In Experiment 2, pair-housed rats received once-daily AMP (1.0 mg/kg i.p.) or SAL for eight days followed by once-daily CTX (200 mg/kg i.p.) or SAL injections for 10 days. CTX treatment reduced cue-induced drug seeking in EC rats but not IC or SC rats. In an AMP-induced reinstatement test, CTX reduced AMP-induced drug seeking in EC and SC rats, but not IC rats. Western blot analyses revealed that AMP self-administration and non-contingent repeated AMP exposure did not downregulate GLT1 or xCT in the NAc or mPFC. Therefore, the ability for EC housing to reduce amphetamine seeking may work through other mechanisms.
AB - Extrasynaptic glutamate within the nucleus accumbens (NAc) is a driver of relapse. Cocaine, ethanol, and methamphetamine reduce the expression of cystine-glutamate antiporter (xCT) and primary glial glutamate transporter 1 (GLT1) leading to increased extrasynaptic glutamate. Ceftriaxone (CTX) restores xCT and GLT1 expression and effectively suppresses cocaine and ethanol reinstatement, however, the effects of CTX on amphetamine (AMP) reinstatement are not determined. Rodents were reared in an enriched condition (EC), isolated (IC), or standard condition (SC) and trained in AMP self-administration (0.1 mg/kg/infusion). EC, IC, and SC rats received injections of SAL or CTX (200 mg/kg) after daily extinction sessions. Then rats were tested in cue- and AMP-induced reinstatement tests. We hypothesized that EC rearing would reduce reinstatement by altering GLT1 or xCT expression in the NAc and medial prefrontal cortex (mPFC). In Experiment 2, pair-housed rats received once-daily AMP (1.0 mg/kg i.p.) or SAL for eight days followed by once-daily CTX (200 mg/kg i.p.) or SAL injections for 10 days. CTX treatment reduced cue-induced drug seeking in EC rats but not IC or SC rats. In an AMP-induced reinstatement test, CTX reduced AMP-induced drug seeking in EC and SC rats, but not IC rats. Western blot analyses revealed that AMP self-administration and non-contingent repeated AMP exposure did not downregulate GLT1 or xCT in the NAc or mPFC. Therefore, the ability for EC housing to reduce amphetamine seeking may work through other mechanisms.
KW - Amphetamine reinstatement
KW - Ceftriaxone
KW - Environmental enrichment
KW - Glutamate transporter GLT1 and cystine-glutamate antiporter xCT
KW - Medial prefrontal cortex (mPFC)
KW - Nucleus accumbens (NAc)
UR - http://www.scopus.com/inward/record.url?scp=85061146112&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061146112&partnerID=8YFLogxK
U2 - 10.1016/j.brainres.2019.01.044
DO - 10.1016/j.brainres.2019.01.044
M3 - Article
C2 - 30716289
AN - SCOPUS:85061146112
SN - 0006-8993
VL - 1712
SP - 63
EP - 72
JO - Brain Research
JF - Brain Research
ER -